Interventions for Promoting Kidney Transplant Empowerment

Recruiting N/A Interventional Study
Kidney Transplant Waitlisting
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
5 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a cluster randomized controlled clinical trial evaluating the effect of community health workers (CHWs) and provider education on kidney transplant (KTx) waitlisting compared to usual care (waitlist control). CKD/HD providers will be randomized to intervention or control, and all patients with the same providers will be in the same randomization group. CHWs will address unmet social needs …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient inclusion: * Provision of signed and dated informed consent from the patient. * Stated willingness to comply with all study procedures and availability for the duration of the study. * Age 18 - 75 years * eGFR≤20 mL/min/1.73m2 or on maintenance in-center HD. …
Contacts

Lili Chan

929-618-0350

lili.chan@mountsinai.org

CONTACT